Study | Research Studies | School of Medicine

Recovery of Patient Reported Outcomes After Intervention for Extremity Metastatic Bone Disease. (REPAIR)

Primary Objective

Determine whether patients undergoing prophylactic nail placement return to at least their preoperative pain interference (PI) and physical function (PF) scores by 6 weeks post operatively.

Is This Study For You?

Let's Get Started!

Description

If you join the study, you will still receive the standard of care for Metastatic Bone Disease (MBD) treatment/procedure as selected by your doctor. All data will be collected during the clinically necessary visits as per standard of care for your condition/procedure. If you give consent to enroll in the trial, we will be utilizing your completed surveys during your pre-operative visit and at the subsequent post-operative visits, 1 week, 2 week, 4 week, 6 week, 10 week, 3 month, 6 month, 1 year, and 2 year.

Details

Age

Adult

Eligibility

Inclusion Criteria: Age group of 30 -99 years of age. Metastatic bone disease who are indicated for surgical intervention for impending pathologic fractures of the femur, Underlying diseases causing pathologic lesions include, but are not limited to, metastatic carcinoma, melanoma, multiple myeloma and lymphoma. Recruitment is open and encouraged to all genders, all minorities, and underrepresented populations. Exclusion Criteria: Under 30 years of age .Patients that are cognitively impaired to the point where they are unable to independently complete a self-assessment or give consent. Pregnant women and prisoners will be excluded. Patients who at the time of presentation and qualifying lesion or fracture have already had a stabilization or implant surgery (present with a periprosthetic fracture) will be excluded.

Locations

University of Colorado Hospital

Principal Investigator

Steven Thorpe

Study ID

Protocol Number: 24-1586

More information available at ClinicalTrials.gov: NCT00000000

Is this Study for You?